In one paragraphArticle in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Juraj KokavecLaboratory of Haematooncology and Stem Cells Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec (BIOCEV), First Faculty of Medicine, Charles University Prague Czech Republic.ORCID https://orcid.org/0000-0003-0267-4570 Tereza TurkováLaboratory of Haematooncology and Stem Cells Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec (BIOCEV), First Faculty of Medicine, Charles University Prague Czech Republic.ORCID https://orcid.org/0000-0002-5329-1812 Björn SchusterCzech Centre for Phenogenomics Institute of Molecular Genetics of the Czech Academy of Sciences Vestec Czech Republic.
František SpoutilCzech Centre for Phenogenomics Institute of Molecular Genetics of the Czech Academy of Sciences Vestec Czech Republic.
Markéta HolečkováLaboratory of Haematooncology and Stem Cells Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec (BIOCEV), First Faculty of Medicine, Charles University Prague Czech Republic.
Karel ChalupskýCzech Centre for Phenogenomics Institute of Molecular Genetics of the Czech Academy of Sciences Vestec Czech Republic.
Inken M BeckCzech Centre for Phenogenomics Institute of Molecular Genetics of the Czech Academy of Sciences Vestec Czech Republic.
Jesús RuberteDepartment of Anatomy and Animal Health, School of Veterinary Medicine Universitat Autònoma de Barcelona Bellaterra Spain.
Matilde ValeLaboratory of Transgenic Models of Disease Institute of Molecular Genetics of the Czech Academy of Sciences Vestec Czech Republic.
Tomáš StopkaLaboratory of Haematooncology and Stem Cells Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec (BIOCEV), First Faculty of Medicine, Charles University Prague Czech Republic.ORCID https://orcid.org/0000-0001-7236-6894 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Diamond-Blackfan anemia (DBA) is a rare bone marrow failure syndrome accompanied by cardiovascular, skeletal, and urogenital abnormalities. Most of the affected individuals carry mutations in ribosomal proteins, including RPS19, a component of the 40S ribosomal subunit. We developed a transgenic
Identifiers
PMID41560850
PMCPMC12813870
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390